Rescue of blood coagulation Factor VIII exon-16 mis-splicing by antisense oligonucleotides

The human Factor VIII (F8) protein is essential for the blood coagulation cascade and specific F8 mutations cause the rare bleeding disorder Hemophilia A (HA). Here, we investigated the impact of HA-causing single-nucleotide mutations on F8 pre-mRNA splicing. We found that 14/97 (∼14.4%) coding sequence mutations tested in our study induced exon skipping. Splicing patterns of 4/11 (∼36.4%) F8 exons tested were especially sensitive to the presence of common disease-causing mutations. RNA-chemical probing analyses revealed a three-way junction structure at the 3′ end of intron 15 (TWJ-3-15). TWJ-3-15 sequesters the polypyrimidine tract, a key determinant of 3′ splice site strength. Using exon-16 of the F8 gene as a model, we designed specific antisense oligonucleotides (ASOs) that target TWJ-3-15 and identified three that promote the splicing of F8 exon-16. Interaction of TWJ-3-15 with ASOs increases accessibility of the polypyrimidine tract and inhibits the binding of hnRNPA1-dependent splicing silencing factors. Moreover, ASOs targeting TWJ-3-15 rescue diverse splicing-sensitive HA-causing mutations, most of which are distal to the 3’ splice site being impacted. The TWJ-3-15 structure and its effect on mRNA splicing provide a model for HA etiology in patients harboring specific F8 mutations and provide a framework for precision RNA-based HA therapies.

[1]  M. V. van Hemert,et al.  SHAPE-guided RNA structure homology search and motif discovery , 2022, Nature Communications.

[2]  E. L. Miller,et al.  A method for campus-wide SARS-CoV-2 surveillance at a large public university , 2021, PloS one.

[3]  A. Laederach,et al.  Disease-associated human genetic variation through the lens of precursor and mature RNA structure , 2021, Human Genetics.

[4]  M. Sattler,et al.  Modulation of pre-mRNA structure by hnRNP proteins regulates alternative splicing of MALT1 , 2021, bioRxiv.

[5]  M. Meisler,et al.  Antisense Oligonucleotide Therapy for Neurodevelopmental Disorders , 2021, Developmental Neuroscience.

[6]  F. Bernardi,et al.  Dissection of pleiotropic effects of variants in and adjacent to F8 exon 19 and rescue of mRNA splicing and protein function. , 2021, American journal of human genetics.

[7]  W. Fairbrother,et al.  Hotspot exons are common targets of splicing perturbations , 2021, Nature Communications.

[8]  M. Gagliardi,et al.  The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery , 2021, Biomedicines.

[9]  N. Gehring,et al.  Anything but Ordinary - Emerging Splicing Mechanisms in Eukaryotic Gene Regulation. , 2020, Trends in genetics : TIG.

[10]  D. Incarnato,et al.  A novel SHAPE reagent enables the analysis of RNA structure in living cells with unprecedented accuracy , 2020, bioRxiv.

[11]  D. Hampshire,et al.  The EAHAD blood coagulation factor VII variant database , 2020, Human mutation.

[12]  D. Hampshire,et al.  The European Association for Haemophilia and Allied Disorders (EAHAD) Coagulation Factor Variant Databases: Important resources for haemostasis clinicians and researchers , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[13]  R. Famà,et al.  Identification and functional characterization of a novel splicing variant in the F8 coagulation gene causing severe hemophilia A , 2020, Journal of thrombosis and haemostasis : JTH.

[14]  H. Stark,et al.  Structural Insights into Nuclear pre-mRNA Splicing in Higher Eukaryotes. , 2019, Cold Spring Harbor perspectives in biology.

[15]  Jinkuk Kim,et al.  Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease. , 2019, The New England journal of medicine.

[16]  D. Bozon,et al.  Splicing analysis of 26 F8 nucleotide variations using a minigene assay , 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

[17]  Danny Incarnato,et al.  RNA Framework: an all-in-one toolkit for the analysis of RNA structures and post-transcriptional modifications , 2018, Nucleic acids research.

[18]  Sol Katzman,et al.  HNRNPA1 promotes recognition of splice site decoys by U2AF2 in vivo , 2017, bioRxiv.

[19]  Pablo Cordero,et al.  Rich RNA Structure Landscapes Revealed by Mutate-and-Map Analysis , 2015, PLoS Comput. Biol..

[20]  Pablo Cordero,et al.  Primerize: automated primer assembly for transcribing non-coding RNA domains , 2015, Nucleic Acids Res..

[21]  X. Xi,et al.  Characterisation and quantification of F8 transcripts of ten putative splice site mutations , 2014, Thrombosis and Haemostasis.

[22]  Y. Hua,et al.  Pharmacology of a Central Nervous System Delivered 2′-O-Methoxyethyl–Modified Survival of Motor Neuron Splicing Oligonucleotide in Mice and Nonhuman Primates , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[23]  Steven Busan,et al.  RNA motif discovery by SHAPE and mutational profiling (SHAPE-MaP) , 2014, Nature Methods.

[24]  Yael Mandel-Gutfreund,et al.  RBPmap: a web server for mapping binding sites of RNA-binding proteins , 2014, Nucleic Acids Res..

[25]  Timothy Sterne-Weiler,et al.  Exon identity crisis: disease-causing mutations that disrupt the splicing code , 2014, Genome Biology.

[26]  P. Radivojac,et al.  MutPred Splice: machine learning-based prediction of exonic variants that disrupt splicing , 2014, Genome Biology.

[27]  J. Oldenburg,et al.  Analysis of F8 mRNA in haemophilia A patients with silent mutations or presumptive splice site mutations , 2013, Hämostaseologie.

[28]  B. Andresen,et al.  Splicing of phenylalanine hydroxylase (PAH) exon 11 is vulnerable: molecular pathology of mutations in PAH exon 11. , 2012, Molecular genetics and metabolism.

[29]  D. Cooper,et al.  Loss of exon identity is a common mechanism of human inherited disease. , 2011, Genome research.

[30]  Jingyue Ju,et al.  Quantitative evaluation of all hexamers as exonic splicing elements. , 2011, Genome research.

[31]  J. G. van der Bom,et al.  Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[32]  Y. Hua,et al.  Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. , 2010, Genes & development.

[33]  David H. Mathews,et al.  RNAstructure: software for RNA secondary structure prediction and analysis , 2010, BMC Bioinformatics.

[34]  J Andrew Berglund,et al.  Role of RNA structure in regulating pre-mRNA splicing. , 2010, Trends in biochemical sciences.

[35]  Peter J. Shepard,et al.  Conserved RNA secondary structures promote alternative splicing. , 2008, RNA.

[36]  Ping An,et al.  Exon Silencing by UAGG Motifs in Response to Neuronal Excitation , 2007, PLoS biology.

[37]  Gene W. Yeo,et al.  A Combinatorial Code for Splicing Silencing: UAGG and GGGG Motifs , 2005, PLoS biology.

[38]  Gene W. Yeo,et al.  Systematic Identification and Analysis of Exonic Splicing Silencers , 2004, Cell.

[39]  E. Buratti,et al.  Exon Enhancer Elements in the Fibronectin EDA Proteins by Mouse and Human Polypurinic RNA Folding Affects the Recruitment of SR , 2004 .

[40]  K. Lynch,et al.  A conserved signal-responsive sequence mediates activation-induced alternative splicing of CD45. , 2003, Molecular cell.

[41]  Christopher B. Burge,et al.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals , 2003, RECOMB '03.

[42]  A. Krainer,et al.  Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1 , 2002, Nature Genetics.

[43]  A. Krainer,et al.  Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. , 2001, Molecular cell.

[44]  T. Maniatis,et al.  The role of U2AF35 and U2AF65 in enhancer-dependent splicing. , 2001, RNA.

[45]  Michael R. Green,et al.  Functional recognition of the 3′ splice site AG by the splicing factor U2AF35 , 1999, Nature.

[46]  Francisco E. Baralle,et al.  Regulation of Fibronectin EDA Exon Alternative Splicing: Possible Role of RNA Secondary Structure for Enhancer Display , 1999, Molecular and Cellular Biology.

[47]  S. Berget.  Exon Recognition in Vertebrate Splicing (*) , 1995, The Journal of Biological Chemistry.

[48]  M. Garcia-Blanco,et al.  Protein–protein interactions and 5'-splice-site recognition in mammalian mRNA precursors , 1994, Nature.

[49]  R. Reed,et al.  A functional association between the 5' and 3' splice site is established in the earliest prespliceosome complex (E) in mammals. , 1993, Genes & development.

[50]  Y. Shimura,et al.  The role of exon sequences in splice site selection. , 1993, Genes & development.

[51]  Michael R. Green,et al.  A factor, U2AF, is required for U2 snRNP binding and splicing complex assembly , 1988, Cell.

[52]  P. Sharp,et al.  Interactions between small nuclear ribonucleoprotein particles in formation of spliceosomes , 1987, Cell.

[53]  C Benoist,et al.  Ovalbumin gene: evidence for a leader sequence in mRNA and DNA sequences at the exon-intron boundaries. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[54]  R. Roberts,et al.  An amazing sequence arrangement at the 5′ ends of adenovirus 2 messenger RNA , 1977, Cell.

[55]  P. Sharp,et al.  Spliced segments at the 5′ terminus of adenovirus 2 late mRNA* , 1977, Proceedings of the National Academy of Sciences.

[56]  T. Maniatis,et al.  6 – Exon Sequences and Splice Site Proximity Play a Role in Splice Site Selection , 1987 .

[57]  R. Amann,et al.  Predictive Identification of Exonic Splicing Enhancers in Human Genes , 2022 .